Burning Rock Biotech (BNR) Total Non-Current Liabilities (2019 - 2025)
Burning Rock Biotech has reported Total Non-Current Liabilities over the past 7 years, most recently at $5.4 million for Q4 2025.
- For Q4 2025, Total Non-Current Liabilities rose 1.15% year-over-year to $5.4 million; the TTM value through Dec 2025 reached $5.4 million, up 1.15%, while the annual FY2025 figure was $5.5 million, 4.24% up from the prior year.
- Total Non-Current Liabilities for Q4 2025 was $5.4 million at Burning Rock Biotech, up from $3.9 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $11.8 million in Q2 2024 and troughed at $1.1 million in Q4 2023.
- A 5-year average of $6.2 million and a median of $5.3 million in 2025 define the central range for Total Non-Current Liabilities.
- Biggest five-year swings in Total Non-Current Liabilities: surged 12797.23% in 2021 and later tumbled 87.88% in 2023.
- Year by year, Total Non-Current Liabilities stood at $9.6 million in 2021, then tumbled by 73.99% to $2.5 million in 2022, then plummeted by 54.02% to $1.1 million in 2023, then surged by 365.17% to $5.3 million in 2024, then rose by 1.15% to $5.4 million in 2025.
- Business Quant data shows Total Non-Current Liabilities for BNR at $5.4 million in Q4 2025, $3.9 million in Q3 2025, and $4.3 million in Q2 2025.